RetinAI is a Swiss & US-based software company improving and supporting R&D of first-in-human drug candidates, supercharging management and oversight of clinical trials and enabling the research needed to elevate the quality of care on patients with eye diseases. 

We achieve this goal by building tools to collect, analyze and to organize health data. Our fundamental belief is that in the future every patient will use drugs alongside a digital application that will enable them and their physicians to better assess the right drug, in the right amount and the right frequency for patients.



Eurostars

Venture Kick

Matterwave Ventures

btov Partners

Verve Ventures

Retinai

BSI has certified our platform RetinAI Discovery and 3 of our #AI models under the Medical Devices Regulation EU 2017/745! This certification underscores our commitment to excellence and compliance with the highest industry standards.

What this means: 
👉 Our quality management system met the rigorous requirements of the EU Medical Device Regulation (EU) 2017/745, ensuring top-tier safety and effectiveness.
👉 Our advanced ophthalmology assessment and diagnostic support technologies, including RetinAI's AI models for Macula Biomarkers, Layer Segmentation and Fluid Segmentation models, have been validated and recognized to meet a healthcare need.
👉 With this certification, we strengthen our position as a trusted pioneer in the AI healthcare technology space.

This milestone is a testament to our team's dedication and the robust quality systems we have in place. Thank you to our team, partners, and clients for their unwavering support.

Together, we are shaping the future of eye care!

For more information, read the press release 👉 https://lnkd.in/ecsjmHQW 

#MDRCertification #AIinHealthcare #Innovation #QualityAssurance #HealthcareTech Ikerian

On Monday, some of our Retinauts gathered for a fantastic barbecue party under the sunny skies of Switzerland's beautiful capital 😎

From exciting games to the Rodelbahn ride, the day was filled with fun and laughter. Our team showed that work and play can blend perfectly!

A big shoutout to our Swiss-based team for organizing such a memorable event. We can't wait for the next adventure!

#TeamBuilding #Retinauts #SwissAdventures #WorkHardPlayHard #CompanyCulture #BernFun

Only 1 week left! Meet Aunia Grogan, our VP Business Development at the 2nd Annual Retinal Imaging Biomarkers & Endpoints Summit in Boston from June 25 to 27.

Aunia looks forward to joining this exciting forum and connecting with leading retinal experts like you!

Schedule your meeting with Aunia to get an overview of our solutions 👉 https://lnkd.in/e5U7kk2Y

See you in Boston!

We're excited to announce that Carlos Ciller, our co-founder and CEO will be a panelist today at the Swiss Medtech Day!

Join the session "The Promise of AI and Large Language Models (LLM) to Transform Healthcare" at 11:30 AM and 2:00 PM.

In this session, we'll explore how AI and LLM are revolutionizing medical device design and the broader healthcare industry. 

Discover the potential and challenges of integrating AI into medical products, from improved diagnostic and predictive analytics to the complexities of regulatory compliance and data privacy.

We look forward to engaging in meaningful discussions about the future of AI in healthcare. If you're attending the event, don't miss this insightful session!

Learn more about the event: https://lnkd.in/e2iscuDb

#SwissMedtechDay #AIinHealthcare #MedicalInnovation #HealthcareTechnology #AIandLLM #RetinAI

We recently sponsored a CPD-registered seminar led by the renowned Prof. Paulo Eduardo Stanga at The Retina Clinic London. This event focused on the state-of-the-art Diagnostic Technologies and Techniques in Retina, and on how AI is transforming clinical workflows in Ophthalmology!

Key highlights of the event:

✅ AI can reshape clinical practice and support diagnostics
✅ AI is integral to streamlining workflows and saving time
✅ Case studies highlighted the potential of AI to revolutionize treatment and patient care

We believe in innovation and are dedicated to supporting those who strive to make a difference.

AI is a powerful tool for healthcare professionals, enabling them to tackle challenging cases more effectively.

If you want to have a demo or get to know our solutions better, visit our website 👉 https://www.retinai.com/

#AIinHealthcare #Ophthalmology #Innovation #ClinicalWorkflows #HealthcareRevolution #FutureOfDiagnostics #MedicalInnovation #AI #HealthcareProfessionals #Eyecare


In a few weeks, we will be participating in the Retinal Imaging Biomarkers & Endpoints Summit in Boston!

From June 25 to 27, you can meet Aunia Grogan at the Hilton Boston Back Bay who will walk you through our data and AI solutions, showing you how RetinAI Discovery can enhance and accelerate imaging analysis for biomarkers, and optimize clinical trial workflows.

If you are attending the Summit, schedule a meeting with Aunia in advance 👉 https://lnkd.in/eF7CXeB3

#ophthalmology #eyecare #research #clinicalresearch #healthcare #digitalhealthcare #artificialintelligence #machinelearning

Domain Not Resolving

SSL by Default

Amazon

IPv6

Amazon S3

Amazon Route 53

Amazon CloudFront

Amazon SSL

Material-UI

Amazon Frankfurt Region

Business Management

Carlos Ciller

Quality & Regulatory Affairs Manager

Huoi Ung

Engineering

Antoine Letouzey

Sales and Support

Dan Coughlan

Markus Ewert

Sandro De Zanet

Christian Schütz

Co-Founder & CEO

Stefanos Apostolopoulos

Sandro Zanet

Chief Scientific Officer

Bern Companies

Europe, Middle East, and Africa (EMEA) Early Stage Companies With Less Than $10M in Revenue

Europe, Middle East, and Africa (EMEA) Companies With Less Than $50M in Revenue (Top 10K)

Information Technology Early Stage Companies With Less Than $10M in Revenue

RetinAI optimises and simplifies clinics, research and pharmaceutical workflows to improve healthcare. To achieve this goal, the company builds tools to collect, analyze and organize health data, empowering healthcare professionals and patients with automatic image and data analysis supported by advanced machine learning. RetinAI has proprietary technology that provides unforeseen image quality enhancement, as well as automatic analysis of medical data for hospitals, private practitioners, pharmaceutical companies and device manufacturers at similar level of performance as a human would produce.

Sanoptis

Series B - Retinai

Topcon Healthcare

Series A - Retinai

Seed Round - Retinai

Grant - Retinai

Pre Seed Round - Retinai

Computer and Software Products and Electrical and Scientific Products

Bern

Switzerland

Europe

Ikerian (parent company of RetinAI U.S. Inc.) receives EU-MDR Certificate for four devices, its Ophthalmology Data Platform and AI models

Ikerian Receives EU-MDR Certificate For Four Devices

Ikerian AG, Parent Company of RetinAI U.S. Inc. Announces Final Close of USD 6.18M (CHF 5.65M) Series A ...

Ikerian Closes USD 6.18M Series A Extension Financing

Swiss-based Ikerian AG secures €5.7M to accelerate healthcare workflows through AI: Here's how

A platform that aggregates data to generate insights on disease biomarkers and outcomes, with predictive analytics for analyzing cause and effect.

A platform for managing data at scale from multiple vendors and data sources, enabling real-time decisions and monitoring during clinical studies.

A modular software solution providing AI for OCT and imaging data, allowing real-time data sharing and analysis.

A platform designed to enhance research analysis by providing AI for OCT data and secure data sharing.

Apps that generate reports on common vision-threatening diseases during patient visits, supporting disease assessment.

An AI model for identifying and quantifying pathological fluid volumes in retinal images.

Turkey

Greece

Poland

Malaysia

Asia

United Kingdom

Mirion is a competitor specializing in AI solutions for healthcare, potentially including applications in ophthalmology.

Mirion

AIdoc is a competitor known for its AI-powered medical imaging analysis and diagnostic solutions, which may overlap with RetinAI's offerings.

AIdoc

Enlitic is a competitor focused on AI-driven medical imaging analysis and diagnostics, potentially competing with RetinAI in the healthcare sector.

Enlitic

GoCheck Kids is a competitor specializing in AI-based pediatric vision screening, potentially overlapping with RetinAI's focus on ophthalmology.

GoCheck Kids

Metaoptima is a competitor known for its AI-powered dermatology solutions, potentially overlapping with RetinAI's AI modules for disease understanding and outcomes.

Metaoptima

Cleerly is a competitor focused on AI-based cardiac imaging analysis, potentially competing with RetinAI in the AI healthcare space.

Cleerly

DiA Imaging Analysis is a competitor specializing in AI-powered ultrasound analysis, potentially overlapping with RetinAI's AI modules for disease understanding and outcomes.

DiA Imaging Analysis

Vista.ai is a competitor known for its AI solutions in the healthcare sector, potentially overlapping with RetinAI's focus on AI modules for disease understanding and outcomes.

Vista.ai

Toku Eyes is a competitor operating in the healthcare sector, potentially offering AI solutions that compete with RetinAI's offerings.

Toku Eyes

VisionQuest Biomedical is a competitor known for its AI solutions in the healthcare sector, potentially overlapping with RetinAI's focus on AI modules for disease understanding and outcomes.

VisionQuest Biomedical

MEDcare Urgent Care is a competitor in the healthcare sector, potentially offering services that compete with RetinAI's offerings.

MEDcare Urgent Care

Methinks is a competitor in the healthcare sector, potentially offering services that compete with RetinAI's offerings.

Methinks

Premier Radiology Services is a competitor in the healthcare sector, potentially offering services that compete with RetinAI's offerings.

Premier Radiology Services

Mercy Radiology is a competitor in the healthcare sector, potentially offering services that compete with RetinAI's offerings.

Mercy Radiology

RetinAI is a technology company that specializes in creating a data management platform integrated with AI modules, designed to improve understanding of patients' diseases and outcomes through enhanced insights and knowledge.

news impact assignment basic	general	Jul 6, 2024 10:28 AM	e0a92256
public peers	general	Jul 5, 2024 9:35 AM	fbfa6453
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general	Jul 5, 2024 10:21 AM	ed10ae36
company summary	general
signals	general
crunchbase trigger	general	Nov 18, 2024 2:12 PM	a7159d35
crunchbase profile	general	Nov 18, 2024 2:25 PM	e3e4922a
li profile	general	Jul 5, 2024 9:35 AM	43c5a9ae
translate crunchbase fundingrounds	general	Nov 18, 2024 2:47 PM	4b9bd6e9
peers	general	Jul 5, 2024 9:35 AM	85a50540
news basic	general	Jul 5, 2024 9:35 AM	391099f1
bundesanzeiger	filings
financials download nd	financials
private financials	financials

COM:RETINAI

RetinAI